214 related articles for article (PubMed ID: 27018255)
1. STAT5A Modulates Chemokine Receptor CCR6 Expression and Enhances Pre-B Cell Growth in a CCL20-Dependent Manner.
Tsuruyama T; Hiratsuka T; Aini W; Nakamura T
J Cell Biochem; 2016 Nov; 117(11):2630-42. PubMed ID: 27018255
[TBL] [Abstract][Full Text] [Related]
2. CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis.
Nandi B; Pai C; Huang Q; Prabhala RH; Munshi NC; Gold JS
PLoS One; 2014; 9(5):e97566. PubMed ID: 24866282
[TBL] [Abstract][Full Text] [Related]
3. Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells.
Skovdahl HK; Granlund Av; Østvik AE; Bruland T; Bakke I; Torp SH; Damås JK; Sandvik AK
PLoS One; 2015; 10(11):e0141710. PubMed ID: 26536229
[TBL] [Abstract][Full Text] [Related]
4. CCL20 is elevated during obesity and differentially regulated by NF-κB subunits in pancreatic β-cells.
Burke SJ; Karlstad MD; Regal KM; Sparer TE; Lu D; Elks CM; Grant RW; Stephens JM; Burk DH; Collier JJ
Biochim Biophys Acta; 2015 Jun; 1849(6):637-52. PubMed ID: 25882704
[TBL] [Abstract][Full Text] [Related]
5. Expression of the chemokine receptor CCR6 in human renal inflammation.
Welsh-Bacic D; Lindenmeyer M; Cohen CD; Draganovici D; Mandelbaum J; Edenhofer I; Ziegler U; Regele H; Wüthrich RP; Segerer S
Nephrol Dial Transplant; 2011 Apr; 26(4):1211-20. PubMed ID: 20844183
[TBL] [Abstract][Full Text] [Related]
6. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
[TBL] [Abstract][Full Text] [Related]
7. Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview.
Frick VO; Rubie C; Keilholz U; Ghadjar P
World J Gastroenterol; 2016 Jan; 22(2):833-41. PubMed ID: 26811629
[TBL] [Abstract][Full Text] [Related]
8. CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions.
Giuliani N; Lisignoli G; Colla S; Lazzaretti M; Storti P; Mancini C; Bonomini S; Manferdini C; Codeluppi K; Facchini A; Rizzoli V
Cancer Res; 2008 Aug; 68(16):6840-50. PubMed ID: 18703490
[TBL] [Abstract][Full Text] [Related]
9. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.
Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110
[TBL] [Abstract][Full Text] [Related]
10. Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages.
Li Q; Laumonnier Y; Syrovets T; Simmet T
Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):593-600. PubMed ID: 23681234
[TBL] [Abstract][Full Text] [Related]
11. In situ expression of the CCL20-CCR6 axis in lymphocyte-rich gastric cancer and its potential role in the formation of lymphoid stroma.
Ohtani H; Nakayama T; Yoshie O
Pathol Int; 2011 Nov; 61(11):645-51. PubMed ID: 22029675
[TBL] [Abstract][Full Text] [Related]
12. The relationship between CCR6 and its binding partners: does the CCR6-CCL20 axis have to be extended?
Lee AY; Phan TK; Hulett MD; Körner H
Cytokine; 2015 Mar; 72(1):97-101. PubMed ID: 25585877
[TBL] [Abstract][Full Text] [Related]
13. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells.
Brand S; Olszak T; Beigel F; Diebold J; Otte JM; Eichhorst ST; Göke B; Dambacher J
J Cell Biochem; 2006 Mar; 97(4):709-23. PubMed ID: 16215992
[TBL] [Abstract][Full Text] [Related]
14. The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma.
Du D; Liu Y; Qian H; Zhang B; Tang X; Zhang T; Liu W
Int J Mol Sci; 2014 Apr; 15(4):6441-52. PubMed ID: 24743888
[TBL] [Abstract][Full Text] [Related]
15. C-C Motif Ligand 20 (CCL20) and C-C Motif Chemokine Receptor 6 (CCR6) in Human Peripheral Blood Mononuclear Cells: Dysregulated in Ulcerative Colitis and a Potential Role for CCL20 in IL-1β Release.
Skovdahl HK; Damås JK; Granlund AVB; Østvik AE; Doseth B; Bruland T; Mollnes TE; Sandvik AK
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347808
[TBL] [Abstract][Full Text] [Related]
16. The chemokine CCL20 induces proinflammatory and matrix degradative responses in cartilage.
Alaaeddine N; Antoniou J; Moussa M; Hilal G; Kreichaty G; Ghanem I; Abouchedid W; Saghbini E; Di Battista JA
Inflamm Res; 2015 Sep; 64(9):721-31. PubMed ID: 26189947
[TBL] [Abstract][Full Text] [Related]
17. CCL20/CCR6 Signaling Regulates Bone Mass Accrual in Mice.
Doucet M; Jayaraman S; Swenson E; Tusing B; Weber KL; Kominsky SL
J Bone Miner Res; 2016 Jul; 31(7):1381-90. PubMed ID: 26890063
[TBL] [Abstract][Full Text] [Related]
18. Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-κB signaling pathway.
Jin P; Shin SH; Chun YS; Shin HW; Shin YJ; Lee Y; Kim D; Nam DH; Park JW
Oncogene; 2018 Jun; 37(23):3070-3087. PubMed ID: 29535421
[TBL] [Abstract][Full Text] [Related]
19. The CCR6-CCL20 axis in humoral immunity and T-B cell immunobiology.
Lee AYS; Körner H
Immunobiology; 2019 May; 224(3):449-454. PubMed ID: 30772094
[TBL] [Abstract][Full Text] [Related]
20. A TNF-α-CCL20-CCR6 axis regulates Nod1-induced B cell responses.
Paradis M; Mindt BC; Duerr CU; Rojas OL; Ng D; Boulianne B; McCarthy DD; Yu MD; Summers deLuca LE; Ward LA; Waldron JB; Philpott DJ; Gommerman JL; Fritz JH
J Immunol; 2014 Mar; 192(6):2787-99. PubMed ID: 24534531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
